|
TEX2 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 7.50019999999907E-05 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.705590E-01 |
| Normal-vs-Stage2 |
1.259810E-02 |
| Normal-vs-Stage3 |
6.590000E-04 |
| Normal-vs-Stage4 |
5.60399504578868E-11 |
| Stage1-vs-Stage2 |
1.020390E-01 |
| Stage1-vs-Stage3 |
1.334420E-02 |
| Stage1-vs-Stage4 |
2.4857000013867E-08 |
| Stage2-vs-Stage3 |
8.066400E-01 |
| Stage2-vs-Stage4 |
2.924200E-02 |
| Stage3-vs-Stage4 |
2.303900E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
9.87120000000008E-05 |
| Normal-vs-AfricanAmerican |
1.667720E-02 |
| Normal-vs-Asian |
6.204600E-01 |
| Caucasian-vs-AfricanAmerican |
6.843000E-01 |
| Caucasian-vs-Asian |
3.766800E-01 |
| AfricanAmerican-vs-Asian |
3.467200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.57510000001293E-06 |
| Normal-vs-Female |
7.536000E-02 |
| Male-vs-Female |
3.385600E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.856400E-01 |
| Normal-vs-Age(41-60Yrs) |
7.81820000000932E-05 |
| Normal-vs-Age(61-80Yrs) |
1.600520E-03 |
| Normal-vs-Age(81-100Yrs) |
5.845400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.132800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.184400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.010400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.922200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.479000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.186200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
6.890400E-01 |
| Normal-vs-Grade 2 |
2.911800E-02 |
| Normal-vs-Grade 3 |
5.69240000000137E-05 |
| Normal-vs-Grade 4 |
7.864400E-03 |
| Grade 1-vs-Grade 2 |
8.275000E-01 |
| Grade 1-vs-Grade 3 |
3.799200E-01 |
| Grade 1-vs-Grade 4 |
4.298600E-01 |
| Grade 2-vs-Grade 3 |
4.227700E-02 |
| Grade 2-vs-Grade 4 |
1.481650E-01 |
| Grade 3-vs-Grade 4 |
8.344800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
6.397700E-02 |
| Normal-vs-ccB subtype |
3.263600E-02 |
| ccA subtype-vs-ccB subtype |
6.114600E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.158400E-04 |
| Normal-vs-N1 |
2.252400E-02 |
| N0-vs-N1 |
4.884400E-01 |
|
|
